"Erectile Function After PCI in MI and Non-MI Patients"
ERECT-PCI
Erectile Function After Percutaneous Coronary Intervention in Myocardial Infarction and Non-Infarction Patients: A Prospective Comparative Study.
1 other identifier
observational
100
1 country
1
Brief Summary
The goal of this observational study is to assess changes in patients' erectile function after percutaneous coronary intervention (PCI) using a standard IIEF (International Index of Erectile Function) questionnaire at 1, 3, and 6 months post-PCI. By doing this, we try to compare patients' responses to PCI after having a heart attack and stable angina to see the real effect of myocardial infarction on erectile function status in the long term by comparing it with a very similar group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2026
CompletedFirst Submitted
Initial submission to the registry
January 20, 2026
CompletedFirst Posted
Study publicly available on registry
March 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
March 3, 2026
February 1, 2026
10 months
January 20, 2026
February 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in erectile function score after percutaneous coronary intervention (PCI)
Description: Erectile function will be assessed using the International Index of Erectile Function-5 (IIEF-5) questionnaire. The primary outcome is the change in mean IIEF-5 score from baseline to 6 months after PCI, comparing patients with myocardial infarction (Group 1) and those with stable angina (Group 2). A decrease in IIEF-5 score indicates worsening erectile function.
Baseline (post-recovery from PCI) to 6 months follow-up]
Secondary Outcomes (3)
Effect of myocardial infarction on post-PCI erectile function
Baseline (post-PCI recovery) and 6 months after PCI
Effect of myocardial infarction on post-PCI erectile function
Baseline (post-PCI recovery) and 6 months after PCI
Association between fear symptoms and post-PCI erectile function Fear symptoms will be assessed using the Beck Depression Inventory (BDI), and their association with erectile function measured by the IIEF-5 will be examined.
Baseline, 3 months, and 6 months after PCI
Other Outcomes (3)
Correlation between SYNTAX score (angiographic coronary disease burden, points) and erectile function score measured by IIEF-5 (points)
Baseline (post-PCI recovery) and 6 months after PCI
Correlation between Beck Depression Inventory (BDI) score (points) and erectile function score measured by IIEF-5 (points)
Baseline, 3 months, and 6 months after PCI
Correlation between composite demographic-procedural risk score (points) and change in IIEF-5 score (points)
Baseline to 6 months follow-up
Study Arms (2)
Group 1
Patients who undergo PCI due to a heart attack
Group 2
Patients who undergo PCI due to a stabile angina
Eligibility Criteria
The study population will consist of adult male patients treated with percutaneous coronary intervention (PCI) for either acute myocardial infarction or stable angina at the Cardiology Department of Kırıkkale University Hospital. Eligible participants will be recruited consecutively after successful PCI and clinical stabilization. The study represents a hospital-based, observational cohort reflecting the typical male population undergoing PCI in a tertiary referral center. All assessments and follow-up visits will be conducted within the same institution's cardiology and urology outpatient clinics.
You may qualify if:
- Male patients aged 30-75 years
- Undergoing successful percutaneous coronary intervention (PCI) for one of the following:
- Acute myocardial infarction (Group 1)
- Stable angina (Group 2)
- Hemodynamically stable after the PCI procedure
- Survival of the index hospitalization
- Ability to provide written informed consent
- Sexually active within the 3 months prior to enrollment
- Willingness and ability to complete follow-up visits and questionnaires at:
- Baseline (post-PCI recovery)
- months
You may not qualify if:
- Known malignancy (active or recently treated)
- Neurological disorders affecting erectile function, including:
- Spinal cord injury
- Multiple sclerosis
- Parkinson's disease
- Uncontrolled diabetes mellitus (HbA1c \> 9%)
- Presence of more than two chronic systemic diseases, such as:
- Severe renal disease
- Severe hepatic disease
- Severe pulmonary disease
- Polypharmacy, defined as chronic use of more than three daily medications
- Absence of sexual activity or lack of a sexual partner
- Refusal or inability to provide informed consent or complete study questionnaires
- Severe psychiatric illness interfering with study participation
- Endocrine disorders, including:
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hospital of Kirikkale Univerity Faculty of Medicine
Kırıkkale, 71450, Turkey (Türkiye)
Related Publications (7)
Dostalova G, Hlubocka Z, Bayerova K, Belohlavek J, Linhart A, Karetova D. Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up. Am J Mens Health. 2017 Nov;11(6):1739-1744. doi: 10.1177/1557988317714359. Epub 2017 Jul 11.
PMID: 28697641RESULTHodzic E, Durek A, Begic E, Sabanovic Bajramovic N. Effect of myocardial infarction on the occurrence of erectile dysfunction. Med Glas (Zenica). 2019 Feb 1;16(1):35-39. doi: 10.17392/981-19.
PMID: 30589239RESULTAdam A, McDowall J, Aigbodion SJ, Enyuma C, Buchanan S, Vachiat A, Sheahan J, Laher AE. Is the History of Erectile Dysfunction a Reliable Risk Factor for New Onset Acute Myocardial Infarction? A Systematic Review and Meta-Analysis. Curr Urol. 2020 Oct;14(3):122-129. doi: 10.1159/000499249. Epub 2020 Oct 13.
PMID: 33224004RESULTClarke ST, Le Grande M, Murphy BM, Hester R, Jackson AC. Protocol for the development and validation of a clinical measurement tool for fear of disease progression and recurrence in cardiac patients. Chronic Dis Transl Med. 2024 Jan 24;10(3):195-204. doi: 10.1002/cdt3.115. eCollection 2024 Sep.
PMID: 39027197RESULTVacanti L, Caramelli B. Distress: associated variables of erectile dysfunction post-acute myocardial infarction. A pilot study. Int J Impot Res. 2005 Mar-Apr;17(2):204-6. doi: 10.1038/sj.ijir.3901274.
PMID: 15538397RESULTMontorsi P, Ravagnani PM, Galli S, Salonia A, Briganti A, Werba JP, Montorsi F. Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient. Eur Urol. 2006 Oct;50(4):721-31. doi: 10.1016/j.eururo.2006.07.015. Epub 2006 Jul 28.
PMID: 16901623RESULTWeintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O'Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE; COURAGE Trial Research Group; Mancini GB. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008 Aug 14;359(7):677-87. doi: 10.1056/NEJMoa072771.
PMID: 18703470RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Timucin Sipal, Assistan Prof
Kirikkale Univerity faculty of medicine department of Urology
- STUDY DIRECTOR
Caglar Alp, Assistant Prof
Kirikkale Univerity Faculty of Medicine department of Cardiology
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistan profesor
Study Record Dates
First Submitted
January 20, 2026
First Posted
March 3, 2026
Study Start
January 15, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
March 3, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to privacy considerations.